'We are very pleased to welcome Javier to Gilead's Board of Directors,' said
About
Contact:
Tel: (650) 522-2739
(C) 2020 Electronic News Publishing, source
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
66.16 USD | -1.15% | -3.63% | -18.33% |
12:33am | US FDA mandates label updates on CAR-T cancer therapies | RE |
Apr. 17 | UBS Adjusts Gilead Sciences Price Target to $75 From $81, Maintains Neutral Rating | MT |
'We are very pleased to welcome Javier to Gilead's Board of Directors,' said
About
Contact:
Tel: (650) 522-2739
(C) 2020 Electronic News Publishing, source
1st Jan change | Capi. | |
---|---|---|
-18.33% | 83.46B | |
+27.97% | 676B | |
+23.58% | 554B | |
-7.02% | 349B | |
+14.85% | 318B | |
+6.25% | 291B | |
+2.96% | 210B | |
-0.41% | 204B | |
-10.02% | 194B | |
-11.81% | 144B |